BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Milani M, Mammarella E, Rossi S, Miele C, Lattante S, Sabatelli M, Cozzolino M, D'Ambrosi N, Apolloni S. Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis. J Neuroinflammation 2021;18:132. [PMID: 34118929 DOI: 10.1186/s12974-021-02184-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ji H, Dong H, Lan Y, Bi Y, Gu X, Han Y, Yang C, Cheng M, Gao J. Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis. Front Pharmacol 2023;14:1089812. [PMID: 36817136 DOI: 10.3389/fphar.2023.1089812] [Reference Citation Analysis]
2 Vastrad B, Vastrad C. Bioinformatics and next generation sequencing data analysis to identify key genes and pathways influencing in Parkinson’s disease.. [DOI: 10.1101/2022.02.27.482208] [Reference Citation Analysis]
3 Tarantino N, Canfora I, Camerino GM, Pierno S. Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle. Cells 2022;11:415. [PMID: 35159225 DOI: 10.3390/cells11030415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]